Lyell Immunopharma LYEL
NASDAQ LYEL
$9.26 -0.15 (-1.59%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lyell Immunopharma (LYEL) Depreciation & Amortization (CF) (2020 - 2026)

Updated

Lyell Immunopharma (LYEL) reported Depreciation & Amortization (CF) of $2.22 million for Q2 2026, down 29.1% from $3.14 million a year earlier and down 4.7% from the prior quarter.

Analysis

Lyell Immunopharma (LYEL) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Lyell Immunopharma's Depreciation & Amortization (CF) came in at $9.52 million, down 41.5% year-over-year; for FY2025, it came in at $11.54 million, down 41.2% from FY2024.

  • Depreciation & Amortization (CF) has a five-year compound annual growth rate of 21.9% (FY2020 to FY2025).
  • By year, Depreciation & Amortization (CF) came in at $19.63 million in FY2024 (-3.1%), $20.25 million in FY2023 (+12.4%), $18.02 million in FY2022 (+32.3%) and $13.62 million in FY2021 (+217.3%).
  • The Q2 2026 figure ranks as the lowest quarterly Depreciation & Amortization (CF) since Q1 2021.
  • Year over year, Depreciation & Amortization (CF) has now declined in each of the last ten quarters, with an average decline of 29.4% over the last eight quarters.
  • The high point for year-over-year Depreciation & Amortization (CF) in five years was Q3 2021 (growth of 270.6%); the low point was Q4 2025 (a decline of 52.3%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $2.33 million (Q1 2026), $2.4 million (Q4 2025) and $2.57 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Lyell Immunopharma 229.06 Mn 229.06 Mn - 2.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.22 Mn
Mar 31, 2026 2.33 Mn
Dec 31, 2025 2.40 Mn
Sep 30, 2025 2.57 Mn
Jun 30, 2025 3.14 Mn
Mar 31, 2025 3.44 Mn
Dec 31, 2024 5.03 Mn
Sep 30, 2024 4.68 Mn
Jun 30, 2024 4.90 Mn
Mar 31, 2024 5.02 Mn
Dec 31, 2023 5.06 Mn
Sep 30, 2023 5.10 Mn
Jun 30, 2023 5.06 Mn
Mar 31, 2023 5.03 Mn
Dec 31, 2022 5.04 Mn
Sep 30, 2022 4.62 Mn
Jun 30, 2022 4.17 Mn
Mar 31, 2022 4.19 Mn
Dec 31, 2021 4.57 Mn
Sep 30, 2021 4.09 Mn
API Access

Lyell Immunopharma Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=LYEL&period=max&api_key=YOUR_API_KEY